Please login to the form below

Not currently logged in
Email:
Password:

Teva Generics Europe appoints president and CEO

Promotes former UK general manager Richard Daniell

Teva Richard DaniellTeva has appointed Richard Daniell as president and chief executive officer of Teva Generics Europe, following Dipankar Bhattacharjee's promotion to a global role.

Daniell has over 25 years of experience working at Teva and served as the company's chief integration officer, leading the integration programme to bring Actavis and Teva together.

Prior to this, he was chief operating officer, growth markets region and served as general manager of Teva UK from 2011 to 2015.

Bhattacharjee, president and chief executive of global generic medicines said: “Richard has shown visionary leadership, has built high-performing teams across the company and has an impressive record in driving commercial success.”

21st December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics